Secondary copy not in EU. So how exactly does that help with compliance?

It sounded like a temporary situation until they get a second EU datacenter.

Need to fix the darn font, reads like "stocks" here....

Spain stone buildings too... common problem modern plaster on those stone walls, folk have forgotten the wall needs to breathe

Many responses (correctly) identifying that edit history is not a reliable "tell" but this misses the broader point of the original article

Author D.Goodin... ok,we know it's wrong. Just how badly wrong takes effort to discover.

Do you have context on this? Is Goodin generally known to be make mistakes?

Article specifically refers to vaccination with live attenuated virus... Should a difference be inferred between Shingrix and Zostavax (in the context of the effect on dementia, not shingles)

Background to the question is providers here seem to be switching to Shingrix for (claimed) higher effectiveness against shingles, but there's at least some suggestion that Shingix is not live (attenuated) virus...

From https://www.ox.ac.uk/news/2025-06-25-how-do-vaccines-reduce-...

> The shingles vaccine now in widespread use (Shingrix) has more of an effect than the previous one (Zostavax). A key difference between these vaccines is that Shingrix contains an ‘adjuvant’, an ingredient designed to enhance the vaccine’s effect. It is therefore possible that the adjuvant contributes to Shingrix’ greater effect than Zostavax on reducing dementia.

Paywalled, UCE